US Sales and Partnerships Lead, Digital Diagnostics

Who We Are PathAI is a health-tech startup focused on utilizing AI-powered pathology to improve patient outcomes. PathAI applies deep learning to the medical field of pathology, which is the “ground truth” for most disease diagnoses including for cancer. PathAI’s 300+ person cross-functional business is the global leader in AI-powered diagnostics and works with the leading biopharma companies and laboratories to improve drug development and clinical care. PathAI is venture backed by leading investors including: D1 Capital, General Catalyst and General Atlantic, as well as by strategic investors like Kaiser Permanente, Merck, BMS, and LabCorp. Context Over the past five years, PathAI has developed many pathology algorithms (across various IO biomarkers and indications in Oncology, Immunology, and Inflammatory Bowel Disease) that aim to tackle major challenges in precision medicine. While most of these algorithms were